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All immune origin of glomerulonephritis,  with complement playing a  major role, 
was first suspected  50 yr ago when it was  found that  serum  complement levels  in 
nephritis were often low.  Only recently however, with the identification of individual 
components, have details of the complement reaction become susceptible to investiga- 
tion. It is already apparent that there are differences  in the way in which complement 
is involved in nephritis. For example, serum levels of individual components have been 
shown to be variably reduced depending upon the type of nephritis (1-3). Furthermore, 
deposition of C3 in the glomeruli occurs in many cases in which C3 and total comple- 
ment levels  have remained  normal during  the course of the  disease  (4-6).  In other 
types of nephritis,  however,  the configuration of C3  deposition correlates well  with 
the supposed target of the immune reaction (4, 5). 
The participation  of complement in  producing  the  type  of nephritis  desig- 
nated  hypocomplementemic persistent  or membranoproliferative  is  of special 
interest.  In this disease  CHs0 and  C3 may remain at very low levels over long 
periods  (6,  7)  and  C3  is  usually  found  in  the  glomerular  capillary  walls  by 
immunofluorescent techniques,  often without the presence of identifiable IgG.  1 
The persistently reduced serum levels of C3 have been explained by some as the 
result of diminished  synthesis  of C3  (8)  and ascribed  by others  to an  ongoing 
complement reaction in the glomeruli in which C3 is continuously being broken 
down  (9).  Recent  observations  suggest  that  a  site  of complement breakdown 
may  be  circulating  plasma.  Inactivators  of  guinea  pig  (10)  and  human  (11) 
complement  have  been  found  in  the  serum  of  patients  with  acute,  chronic 
hypocomplementemic,  and  lupus  nephritis,  and  in  a  previous  communication 
from this ]nboratory, Spitzer et al.  (12) reported the presence of a factor in the 
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serum  of  a  patient  with hypocomplementemic  persistent  (membranoprolifera- 
tive) glomerulonephritis which  was  involved specifically  in  the  breakdown  of 
serum  C3.  This  factor,  designated  C3  nephritic  factor  (C3NeF),  appeared  to 
combine  with  a  cofactor  present  in  normal  human  serum  in  the  presence  of 
Mg  ++ to form a  complex which rapidly cleaves C3. The cleavage of C3 resulted 
in the loss of antibody reactivity of the B  antigenic determinant  of C3 and the 
formation  of  two  breakdown  products,  /~IA  and  a2D  (13).  This  inactivator 
complex  was  named  the  C3  lyric  nephritic  factor  (C3LyNeF).  Neither  the 
nephritic  factor  nor  the  cofactor  was  identifiable  with  components  of  the 
complement system. Details of the studies reported previously in brief form (12) 
TABLE I 
Levels* of B Antigenic Determinant, ¢IA, C4, and C5 in HGS 
B antigeM,  iliA§  C411  C51I 
units/ml  mg/lO0 ml  mg/lO0 ml  mg/lO0 ml 
HGS  2.9  17.6  33.6  6.5 
Normal serum  > 20  > 90  27-67  5.5-11 
* Measured by the immunoelectrophoretic precipitin method (15). 
:~ See text for details on method of measurement. 
§ Measured after sample had aged at 37°C for 1 wk (7). 
[[ Methods standardized  to express results in milligrams by means of a  standard  serum 
kindly supplied by Dr. Peter F. Kohler. 
as well as the results  of additional  work characterizing  these factors  and  their 
reaction are reported herein. 
Materials  and Methods 
Serum from a Hypocomplementemic Patient with Membrano Proliferative Glomerulonephritis 
(HGS)  Containing Nephritic Factor.--The studies  to be reported were performed on serum 
obtained  at one time in July  1968, from a  patient with severe hypocomplementemic mem- 
branoproliferative glomerulonephritis in renal failure. The clinical course of the patient  (MF) 
has been described previously (14).  The blood was obtained  by exchange transfusion  with 
packed  red blood cells.  After clot formation at 25°C,  the serum was immediately separated 
by centrifugation at 4°C  and  cooled.  2 ml portions were stored at  -70°C  until used.  The 
levels of the B  antigen of C3, of C3  (iliA), C4 (/~IE),  and C5  (]~IF) in this serum specimen 
are given in Table I. 
Normal Human  Serum (NttS).--Blood was obtained from healthy donors and the serum 
separated  as described above. The serum was either used on the day obtained or stored at 
-- 70°C. 
Antiserum to A, B, and D Determinants of C3.--Antiserum  to C3 determinants was produced 
by injection of highly purified C3 incorporated in complete Freund's adjuvant into goats as 
described previously (13). Disodium ethylenediaminetetraacetic acid (EDTA) was frequently 
added  to  the sallne-antigen solution before incorporation  in  the adjuvant.  The method  of 
absorption of the antiserum to remove antibody to other proteins without removing that to 
specific C3 determinants was described earlier (13). 1308  NON-COMPLEMENT-DEPENDENT  C3-REACTIVE  COMPLEX 
Euglob~din and Psemloglobulin Fractiom.--Sernm  was  fractionated  into  euglobulin  and 
pseudoglobulin by dialysis against 8  X  10  -3 •  EDTA, pFI 5.4,  with a conductance of 1.25 
millimhos per cm as described by Polley et al.  (17). After centrifugation, the pseudoglobulin 
was dialyzed overnight against 0.2  M phosphate buffer, pH 7.5, containing 0.9% NaC1.  The 
euglobulin was washed three times with the same buffer as used for the initial dialysis and, 
after centrifugation, reconstituted with 0.3 M phosphate buffer,  pH 8.1, containing 1% NaC1, 
2 X  10  -4 ~t EDTA and  1 >(  10  -3 ~  NaF. The final volume was ~  to ~  that of the original 
serum.  The solution was then dialyzed overnight against  the same buffer.  For experiments 
in which EDTA or NaF would interfere with the reaction,  these were removed by a  final 
dialysis against 0.02 M phosphate buffer,  pH 7.5. 
Quantitation of the B Antigen.--The concentration of the B antigen of C3 was determined 
by addition of increasing volumes of the solution to be quantitated  to constant volumes of 
standardized antiserum with detection of the end point by double diffusion  of the supernatant 
against  antigen as described previously  (15). The  C3  contained  in normal  human  plasma, 
obtained by drawing blood into EDTA, was used as antigen. The plasma was stored at --70°C. 
For part  of the study  the end point was determined  by reacting the supernatants  against 
EDTA plasma electrophoresed in agar as described in the original method (9,  15). However, 
for some determinations  the original method was modified to determine the end  point by 
double  diffusion  of supernatant  against  EDTA plasma  without  electrophoresis,  essentially 
as in the method described by Wright (18). When this modification was employed, the EDTA 
plasma used as a source of antigen was diluted 1:25, whereas the dilution was 1:10 when the 
EDTA plasma was electrophoresed in agar. The modification also required restandardization 
of the antiserum. Samples of a pool of human EDTA plasma stored at  --70°C were used to 
standardize modifications of the method or new batches of antiserum. Every effort was made 
to keep the arbitrary units used to express B antigen concentration constant throughout the 
study and representative of the same amount of antigen as in previous communications from 
this laboratory (9,  12). 
I~ESIYLTS 
In  this  as  in  previous  studies  (9,  12)  the  concentration  of  the  B  antigenic 
determinant  has been used as a  measure of intact  C3  in  the  mixtures  of  NHS 
and HGS and disappearance  of the B  antigen used to quantitate  C3 breakdown. 
The  loss of the B  antigen  and  the formation  of the breakdown  products  ~IA 
and  ~2D  during incubation  of mixtures  of HGS  and NHS  is illustrated  in  the 
immunoelectrophoretic pattern in Fig. 1. 
Velocity of the Reaction.--The velocity of C3 breakdown  was estimated by B 
antigen  disappearance  in a  number  of experiments  in which mixtures  of equal 
volumes of NHS  and HGS were incubated  at 37°C at pH  7.6 for various inter- 
vals. As illustrated in Fig. 2,  the concentration of B  antigen rapidly diminished 
with incubation  and the B  antigen remaining after 20 rain was between  10 and 
20%  of  that  initially  present.  When  the  period  of  incubation  was  extended 
beyond 20 min, to as long as 120 rain, virtually no further breakdown  occurred. 
The  time  curve  of  B  antigen  reduction  is  similar  to  that  of  substrate  disap- 
pearance seen with most enzyme systems. 
Effect of pH.--The  effect of pH was assessed in mixtures of equal volumes of 
NHS  and HGS as in the above experiments. To vary the pH, NaOH, 0.5 1% and VALLOTA,  FORRISTAL, SPITZER~ DAVIS~ AND  WEST  1309 
HC1, 0.5 N, were added to NHS and HGS before mixing. Between pH 6 and 9, 
as shown in Table II, the extent of breakdown of C3 remains constant. 
It  was  found  that  below  pH  6,  acidity itself  effects  the  B  antigen  or  its 
measurement.  At pH 4.1,  the  B  antigen concentration  of NHS  was less than 
half its value at pH 7.7.  Diminished reactivity of C3 with antibody at low pH 
has been noted by other investigators (19, 20). 
FIG.  1.  Immunoelec~rophoretic pattern of NHS and a mixture of NHS and HGS incubated 
at 37°C for 20 min. Top and bottom wells contain NHS which have undergone electrophoresis 
without incubation. In the middle well was placed the mixture of NHS and HGS after incuba- 
tion.  Antibody to the B determinant resulted in a typical C3 arc with NHS  (top well) and 
no arc with the incubated mixture  (middle well, top), indicating loss of the B determinant 
with incubation.  Antibody to the A and D  determinants reveals the presence  of/31A and 
a2D in the incubated mixture (middle well, bottom), indicating breakdown of C3, and pro- 
duces  a  typical C3  arc with NHS in the bottom well. Agar contained 0.01 •  Na2-EDTA. 
Anode is to the right. 
Evidence  for  the  Participation  of  a  Cofactor.--Evidence  that  the  reaction 
required a  cofactor came from studies of pseudoglobulin and  euglobulin frac- 
tions. Both fractions were dialyzed before use to rid them of EDTA  and NaF. 
As seen in Table III, HGS caused rapid disappearance of the B  antigen when 
added to NHS  but had no effect on the B  antigen when  added to euglobulin 
made from NHS. For breakdown to occur, it was necessary to add NHS pseudo- 
globulin. 
Further fractionation studies indicated that the active factor in HGS was also 
exclusively present  in  the  pseudoglobulin fraction  as  shown  in  the  last  two 
experiments  in  Table  III.  We  conclude  from  these  observations  (a)  that  a 
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C3NeF found in HGS and  (b)  that both the cofactor and  C3NeF are pseudo- 
globulins. Alone, C3NeF has no effect on C3 and it must be activated by reac- 
tion with  cofactor,  presumably  to form  a  complex,  the lyric nephritic factor 
designated C3LyNeF, before breakdown can be effected. 
Evidence for Dependence on Mg++.--When EDTA or NaF was added to NHS 
before mixing with HGS, breakdown of C3 was completely inhibited. The time 
of addition of EDTA and NaF was found to be important in the inhibition. As 
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FIG. 2.  Rate  of disappearance of B  antigen in mixtures  incubated at 37°C containing 
equal volumes of NHS and HGS. 
FIG. 3.  Effect of incubation on activity of C3LyNeF. Extent of breakdown of C3 produced 
by C3LyNeF which has been incubated at 37°C for periods varying from 5 to 120 rain before 
reacting with C3. C3 breakdown  occurred during  a second incubation of 20 min duration. 
illustrated in Table  IV,  when  NHS  and  HGS were  mixed in  the presence  of 
NaF, no breakdown occurred. However, when NaF was added after the serums 
were  mixed,  the reaction was not  inhibited and  the  B  antigen  concentration 
diminished with further incubation at the same rate as in the control mixture in 
which NaCI was substituted for NaF. Other experiments showed that if only 15 
sec elapsed before addition of NaF, breakdown was not significantly inhibited. 
These experiments are compatible with a  two-step reaction as described above 
and indicate that the formation of C3LyNeF occurs rapidly and requires the 
presence of divalent cation. 
To  determine whether  Ca  ++  or Mg  ++ was needed for  the reaction, various VALLOTA,  FORRISTAL~  SPITZER~  DAVIS~  AND  WEST  1311 
concentrations  of each  ion were  added to  reaction mixtures  (Table V).  Con- 
centrations of Mg  ++ as low as 1/6 that in serum allowed cleavage of C3 to occur; 
addition of Ca  ++  , even to concentrations four times that in serum, resulted in no 
C3 breakdown. 
TABLE II 
Effect of pH on Breakdown of C3 in Mixtures of Equal Volumes of NHS and HGS 
pH  Initial B antigen concentration*  B antigen concentration after 
incubation at 37°C for 10 rain 
units  per ml  units per ml 
9.0  22.7  5.3 
7.5  23.1  5.0 
6.0  22.0  5.0 
* Mixture made at 0°C and immediately quantitated for B antigen. 
TABLE III 
Demonstration of Requirement  for Cofactor 
Mixture 
B antigen after in-  Amount 
cubation for  of C3 
break- 
0 rain*  20 min~  down 
NHS +  HGS 
NHS euglobulin +  HGS 
NHS euglobulin +  HGS +  NHS pseudoglobulin 
NHS  euglobulin  +  HGS  pseudoglobulin  +  NHS  pseudo- 
globulin§ 
NHS euglobulin +  HGS euglobulin +  NHS pseudoglobulin§ 
units/ml  units/ml  % 
23.8  3.2  87 
20.4  19.2  6 
12.9  2.2  83 
16.1  3.8  77 
17.1  16.1  6 
* Reactants mixed at 0°C and immediately quantitated. 
:~ Incubation at 37°C. 
§ Sufficient MgC12 added to produce final concentration of 1.25 m~/liter. 
The reaction sequence can now be written as follows: 
C3NeF +  cofactor Mg+~ C3LyNeF 
C3LyNeF +  C3  ~/31A +  a2D 
Evidence for  a  Non-Complement  Origin  of C3LyNeF.--Although  the  above 
experiments indicate that C3LyNeF resembles C3 convertase, C4~  (21), in the 
conditions necessary for its formation and in its action on C3, there are a number 
of points of evidence indicating that convertase is not involved. Some of these 
were discussed in the previous publication (12). Further evidence is provided by 
an experiment designed to show that the formation of C3LyNeF could occur 
under  conditions  in  which  the  formation  of  convertase  was  blocked.  Serum 1312  NON--COMPLEMENT-DEPENDENT C3-REACTIVE  COMPLEX 
from a  patient with hereditary angioneurotic edema (HANE  serum)  obtained 
during an episode of abdominal pain  2 was incubated for 3 hr at 37°C. As shown 
in Table VI, convertase could not be formed when the incubated HANE  serum 
was the source of complement. Thus,  when an immune precipitate was mixed 
TABLE  IV 
Effect o/ Order of Addition of Reagents on C3 Breakdown by Nephritic Factor 
Order of reagent  addition* 
B antigen after incubation at 37°C 
0 min~  2 hr 
units/ml 
NHS  +  NaF§ +  HGS  15.5  15.0 
NHS +  HGS +  NaF§  15.5  1.5 
NHS +  NaCl +  HGS  15.5  1.6 
* The final volume in all mixtures was constant. 
:~ Reagents at 37°C when mixed; mixtures immediately reduced to 0°C. 
§ Final concentration of NaF in reaction mixture was 7.5  X  10  -3 M. 
TABI.E  V 
Effect o.[ Various Concentrations Of Mg ++ and Ca ++ on Formation o[ C3LyNeF 
Ca  ++ or Mg  ++ concentration  of  B antigen concentration  Amount of C3 breakdown 
pseudoglobulin  mixture*  after final incubation 
raM~liter  units/ml  % 
0  13.5  0 
0.2 Mg  ++  4.7  65 
0.4  "  4.9  64 
0.8  "  4.1  70 
1.5  Ca ++  13.7  0 
4.8  "  13.5  0 
10.0  "  15.7  0 
* Pseudoglobulin fractions from NHS  and HGS  from which Ca  ++ and Mg  ++ had been 
removed were mixed, Mg  +÷ or Ca  ++ added as MgC12 or CaC12, 0.15 M NaCI added to bring 
all mixtures to a common volume, and the mixtures incubated at 37°C for 5 min. Euglobulin 
from NHS  containing no  Ca  ++  or Mg  ++ was then added and  the mixtures incubated an 
additional 20 rain at 37°C  before measurement of B antigen. 
with the HANE  serum and with normal euglobulin as a  source of C3, no break- 
down of C3  occurred as compared with marked breakdown on addition of the 
precipitate  to  NHS.  However,  addition  of  either  fresh  or  aged  HGS  to  the 
incubated HANE  serum resulted in marked breakdown of C3.  Thus C3 break- 
down  by  C3LyNeF  is  not  dependent on  the  components or  mechanisms re- 
sponsible for convertase formation. 
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Effect of Storage and Heating on C3NeF, Cofactor, and C3L  yNeF.--Incubation 
of HGS for 1 wk at 37°C had no effect on the activity of C3NeF. No diminution 
in  activity was apparent when HGS so incubated was then stored at  -20°C 
for as long as 17 months. 
Prolonged storage of NHS at -  70°C had no effect on the activity of cofactor. 
At 37°C,  cofactor in NHS retained nearly full activity for 16 hr, but was com- 
pletely  destroyed  after  24  hr.  NHS  lost  40%  of  its  cofactor activity when 
stored at 4°C for 1 wk. 
To determine the stability of C3LyNeF, normal human pseudoglobulin as a 
source of cofactor, and Mg  ++, were added to HGS to form C3LyNeF and the 
mixtures  incubated for varying periods at 37°C.  NHS containing EDTA was 
TABLE VI 
C3LyNeF Activity in Mixtures Lacking Active C4 and C2 
B antigen after incubation 
Reaction mixtures  at 37°C for  B antigen 
reduction 
0 min  20 min 
units/ml  unils/ml 
Immune ppt. +  HANE +  NHS euglobulin  35.5  35.5  0 
Immune ppt. +  NHS  27.5  4.3  23.2 
Fresh HGS +  HANE +  NHS euglobulin  35.8  19.0  16.8 
Aged HGS:~ +  HANE +  NHS euglobulin  26.7  11.2  15.5 
* Immune precipitate was formed at  equivalence from bovine serum albumin (BSA)- 
goat anti-BSA. 
:~ HGS incubated at 37°C for 1 wk. 
then added to supply C3 and the mixtures again incubated at 37°C for 20 rain. 
As seen in  Fig.  3,  there was a  linear relationship  between the  disappearance 
of B  antigen from the  final  reaction mixture  and  the  time  of incubation  of 
C3LyNeF. C3LyNeF thus appears to be relatively unstable  at 37°C with all 
activity lost in 60 rain at this temperature. 
Both  C3NeF in HGS pseudoglobulin and  cofactor in NHS pseudoglobulin 
were partially destroyed by heating at 56°C for 30 rain and were completely 
destroyed after 1 hr at this temperature. 
Effect of Temperature on the Reaction.--The  temperature  sensitivity  of  the 
total reaction was tested by mixing equal volumes of NHS and HGS at 0°C and 
then  incubating the  mixtures  at  other temperatures.  The  temperature  sensi- 
tivity of each step of the two-step reaction was also determined. 
The total reaction is markedly temperature sensitive. As seen in Table VII, 
there  is  virtually no breakdown of C3 in 90 rain with incubation at 0°C and 
25°C. At 32°C,  breakdown occurs very slowly and is  incomplete  at 90 rain  as 
compared to the rapid and extensive breakdown at 37°C. 1314  NON-COMPLEMENT-DEPENDENT  C3-REACTIVE  COMPLEX 
The  temperature  dependence  of  the first step of  the reaction was  tested  by 
incubating  mixtures  of  NHS  pseudoglobulin  and  HGS  pseudoglobulin  in  the 
presence  of  Mg  ++ at various  temperatures  to form C3LyNeF.  After  this incu- 
bation, NHS  euglobulin containing EDTA  was added as a  source of C3 and the 
incubation  continued  at  37°C  for  20  min.  Table  VIII  shows  that  C3LyNeF 
TABLE  VII 
Effect of Temperature on Breakdown of C3 in Mixtures of Equal Volumes 
of NttS and HGS* 
Initial B antigen  Temperature  concentration 
B antigen concentration after incubation 
30 min  90 min. 
°c  units/ml  units/mI  units/ml 
0  16.9  16.9  16.9 
25  17.2  14.2  14.2 
32  16.9  14.4  8.0 
37  17.1  2.2  1.3 
37  16.9  2.9  1.4 
* All mixtures were made at 0°C.  For  the initial B  antigen quantitation, 0.075  ~  NaF 
was added and samples quantitated immediately after mixing. 
TABLE  VIII 
Effect of Temperature on C3LyNeF Formation* 
Initial B antigen  B antigen concentration after  Amount  of C3 
Temperature  concentration  second incubation  breakdown 
°C  units/ml  units/ml  % 
4  19.2  19.2  0 
25  22.7  22.2  3 
32  22.7  19.2  15 
37  19.2  13.1  32 
37  22.7  16.0  30 
* Mixtures of NHS pseudoglobulin and HGS pseudoglobulin  containing Mg  ++, made at 
0°C, were incubated 5 min at the indicated temperatures to form C3LyNeF. After incubation, 
C3,  as NHS euglobulin containing EDTA,  was added and the mixtures incubated again at 
37°C for 20 rain. 
formation was partially inhibited at 32°C and completely inhibited at 25°C and 
0°C. ~ The results are similar to those for the total reaction shown in Table VII. 
To  test the temperature  dependence  of the breakdown  of  C3  by  C3LyNeF, 
C3LyNeF  was  produced  by  incubating  mixtures  of  NHS  pseudoglobulin  and 
3 The amount of C3 breakdown occurring in mixtures containing certain batches of pseudo- 
globulin and euglobulin was less than that seen in mixtures of NHS and HGS. Although the 
percentage breakdown with these batches was low,  as in this experiment, the results were 
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HGS  pseudoglobulin  at  37°C  with  Mg  ++.  After  5  min  of incubation,  NHS 
euglobulin containing EDTA was added  and incubation  continued  at various 
temperatures  as shown in Table IX. The results differed from those described 
above in that breakdown at 25°C and 32°C nearly equaled in magnitude that at 
37°C. 
It can be inferred  from these results  that  the  breakdown  of C3  during  the 
second  step  of the  reaction  is  relatively  insensitive  to  temperature  and  that 
formation  of  C3LyNeF  is  highly  temperature  sensitive,  resulting  in  a  high 
sensitivity of the total reaction. 
Effect of Concentration  of C3NeF and of C3 on the Rate of C3 Breakdown.- 
The effect of various C3NeF concentrations on the rate of C3 breakdown was 
assessed in a series of experiments in which the initial concentrations of C3 and 
cofactor were maintained  constant and the amount of C3NeF,  added as HGS, 
TABLE IX 
Effect of Temperature on C3 Breakdown by C3LyNeF* 
Initial B antigen  B antigen concentration after  Amount of C3 
Temperature  concentration  second incubation  breakdown 
°C  units/ml  units/ml  % 
4  16.6  16.5  0 
25  16.6  12.0  28 
32  16.6  11.1  33 
37  16.6  10.3  38 
* Mixtures  of NHS pseudoglobulin and HGS pseudoglobulin containing Mg  ++, made at 
0°C, were incubated  at 37°C for 5 min. After incubation, C3, as NHS euglobulin containing 
EDTA, was added and the mixtures again incubated  20 min at the indicated temperatures 
varied. The mixtures were brought to a common volume and incubated 20 min 
at 37°C. The results of three experiments in which the initial B  antigen concen- 
trations were 38, 19, and 9 units/ml are shown in Fig. 4 a, b, and c, respectively. 
In each experiment,  C3NeF concentration in the reaction mixture was varied 
by including HGS  in volumes of 0.033  to 0.1  ml.  The final  reaction  mixture 
volume was kept constant at 0.4 ml. When the initial B  antigen concentration 
was 38 units/ml  (Fig. 4 a) the loss of the B  antigen was linearly related to the 
concentration of C3NeF but at B  antigen concentrations of 19 units/ml  (Fig. 
4 b)  the  curve  levels  off as  C3NeF  concentration  is  increased.  Breakdown  in 
mixtures containing 9 units/ml of B  antigen  (Fig. 4 c) was variable and was of 
approximately  the  same  magnitude  at  all  concentrations  of  C3NeF.  At low 
C3NeF concentrations, the amount of breakdown tended to be about the same 
regardless  of the initial  B  antigen concentration and in no experiment did the 
line relating  C3NeF concentration to breakdown go through the origin. 
In Fig. 5 are plotted the results of an experiment in which the concentration 
of C3NeF is kept constant at a high level and initial C3 concentration varied. At 18' 
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initial  C3 concentrations giving B  antigen levels between 24 and 40 units/ml, 
the  rate  of breakdown  is  constant,  suggesting  that  C3: C3NeF  ratios  in  this 
range are optimal and maximum velocity is obtained.  As the initial  B  antigen 
concentration  is lowered,  C3 breakdown  diminishes  at a  rate linearly  related 
to initial  C3 (B antigen)  concentration. 
The  above  data  would  suggest  that  the  conditions  for measuring  C3NeF 
are optimum when the mixture has a  B  antigen concentration greater than 25 
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FIG. 5.--Breakdown  of C3 versus initial  B antigen  (C3) concentration  at constant  con- 
centrations  of C3NeF. The reaction mixture consisted of 0.1 ml of HGS and 0.3 ml of NHS 
at various dilutions. 
units/ml.  At these high concentrations,  the rate of breakdown is independent 
of the initial  C3 concentration (Fig. 5), and changes in rate are linearly related 
to C3NeF levels (Fig. 4 a). These observations provide further evidence of the 
enzymatic character of the reaction. 
Effect of Concentration of Cofactor on Rate of C3 Breakdown.--The effect of 
variable C3LyNeF concentrations, produced by varying the amount of cofactor 
in the mixture,  was studied in mixtures  containing constant amounts of HGS 
and  Mg  ++  and  with  variable  amounts  of NHS  as  the  source  of cofactor.  In 
FIG. 4 a, b, and c. Breakdown of C3 versus amounts of C3NeF in reaction mixture when 
initial B antigen (C3) concentrations are 38, 19, and 9 units/ml,  respectively. The concentra- 
tion of cofactor in each series was optimum. 1318  NON-COMPLEMENT-DEPENDENT  C3-REACTIVE  COMPLEX 
other  experiments variable amounts of  NHS  pseudoglobulin were  used  as  a 
source  of  cofactor.  The mixtures were  incubated at  37°C for  5  min to  form 
C3LyNeF. Then, NHS euglobulin containing EDTA was added as a source of 
C3 and incubation continued. The amount of B antigen disappearing during the 
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Fro.  6.--Effect  of variable  amounts  of cofactor. Reaction  mixtures of constant volume 
and HGS content but containing variable amounts of NHS as a source of cofactor (abscissa) 
were incubated. The C3 lyric activity of the C3LyNeF formed was tested by adding NHS 
euglobulin containing EDTA and continuing the incubation.  The 13  antigen concentration 
in each tube at the start of the second incubation was always in the range in which the extent 
of C3 breakdown was independent of C3 concentration (Fig. 5). 
second incubation  in the experiment in which NHS was the source of cofactor is 
shown in Fig.  6.  It is readily apparent that  the reaction is very sensitive to 
C3LyNeF  (cofactor)  concentration. The line goes  through  the  origin and as 
the C3LyNeF (cofactor) concentration increases, as expressed by the increasing VALLOTA, FORRISTAL, SPITZER,  DAVIS, AND  WEST  1319 
NHS in the mixtures, the amount of breakdown increases rapidly to level off 
as  optimal  concentrations  are  attained.  The  same relationship  was  observed 
when NHS pseudoglobulin was used as the source of cofactor. 
DISCUSSION 
The experiments presented in this paper are compatible with the presence of a 
preenzyme, designated C3NeF, in the serum of a hypocomplementemic patient 
with  membrano-proliferative  g]omerulonephritis  (HGS).  Our  studies  reveal 
that in a mixture of fresh NHS and HGS, intact C3 rapidly disappears (Fig. 2) 
and  two  breakdown  products  are  formed,  both  with  a  faster mobility  than 
native C3 (Fig. 1). Failure to obtain breakdown when the euglobulin fraction of 
NHS is substituted for NHS as the source of C3 indicates that a cofactor present 
in  the  pseudoglobulin  fraction  of normal  human  serum  is  necessary for  the 
formation of the active form of C3NeF,  designated  C3LyNeF.  C3LyNeF ap- 
pears to be an enzyme with C3 as substrate. The time course of C3 breakdown 
by C3LyNeF  (Fig.  2),  the  temperature dependence  of the reaction,  and  the 
dependence of C3NeF  (Fig.  4 a, b ,and c),  cofactor (Fig.  6),  and  C3  (Fig.  5) 
concentrations on rate of C3 breakdown are all consistent with an enzymatic 
reaction. 
Inactivation of C3 by enzymatic cleavage and subsequent appearance of an 
inactive product with  a  faster electrophoretic mobility has been described in 
cell-free solutions  (21).  The inactivating enzyme in this study was a  comple- 
ment complex formed by C4 and C2,  designated C3  convertase (C,4, 2). This 
complex can also be bound to a cell surface and in this position produces both 
cytolytically active C3  and inactive C3  (22).  The characteristics of formation 
and mechanism of action of C3LyNeF as described  in the present paper are 
similar to those described for the formation and action of C3 convertase. How- 
ever, several lines of evidence indicate that the mechanism of C3 breakdown 
does not depend on the presence of active C4 or C2 in the serum mixture or on 
the formation of convertase.  (a)  Serum from a patient with hereditary angio- 
neurotic  edema,  incubated for 3  hr at 37°C,  would not supply the first three 
reacting complement components (23,  24) necessary to produce C3 breakdown 
by an immune precipitate but was as effective as NHS in supplying cofactor. (b) 
Prolonged treatment of serum with ammonium sulfate, causing destruction of 
C44, does not affect its cofactor content.  (c) Ancillary studies ~ have shown that 
cofactor does not lose its activity during its isolation by serum fractionation and 
column chromatography as is the case with C2  (17).  (d)  The half-life of con- 
vertase has been found to be 17 rain (21),  whereas half of C3LyNeF is inacti- 
vated in 30 rain (Fig. 3).  (e) The curve relating the activity of C3LyNeF (Fig. 
3) to its time of incubation differs markedly from that for convertase (21). Thus, 
4 Davis, N. D. Unpublished observations. 
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it  seems  highly improbable  that  C3LyNeF is  dependent  for its  activity  on 
any of the first three reacting components or on the formation of convertase. 
The anticomplementary activity observed in this study can be differentiated 
from  that  classically described  in  the  serum  of patients  with  other  chronic 
diseases, systemic lupus erythematosus particularly (25).  Classical serum anti- 
complementary activity  is  usually  ascribed  to  the  presence  of  aggregated 
gammaglobulin and is not affected by heating the serum to 56°C for 1 hr. In 
fact,  anticomplementary activity may be  produced by  this  treatment  (26). 
Similar heating  of HGS, however,  caused loss  of C3NeF  activity. Likewise, 
aggregated gammaglobulin in the NHS was ruled out by the fact that prolonged 
storage of NHS which would favor formation of aggregated gamma globulin 
(25)  caused loss of cofactor activity. Thus, it is difficult to ascribe the break- 
down of C3 to the presence of aggregated gamma globulin in the serum mixture. 
Further,  aggregates as well as classical antigen-antibody or antibody-comple- 
ment (27) complexes would breakdown C3 only through the participation of the 
first three reacting components of the complement sequence which, as has been 
shown above, need not be present in the reaction mixture. 
The C3NeF inactivator system is not identifiable with  the  C3  inactivator 
(C3INA),  nor with KAF (28)  since both are heat stable and affect only cell- 
bound C3, whereas C3NeF is heat labile and affects fluid phase C3. 
C3NeF  and  cofactor  cannot  be  identified  with  factors  liberated  during 
clotting; heparinized plasma from patients with hypocomplementemic nephritis 
and  from normal  individuals  have  the  same  C3NeF  and  cofactor activity, 
respectively, as serum. 
Recently,  Pickering  et  al.  (10)  reported  that  the  serum  of  hypocomple- 
mentemic  patients  with  acute  and  chronic glomerulonephritis  inhibited  the 
hemolytic  activity  of  guinea  pig  complement.  The  inhibition  required  the 
presence of divalent cation and was abolished by preheating the serum to 56°C 
for 30 rain. It could be determined that the inhibition was directed at one or 
more of the six terminal complement components, since lysis not only of EA but 
also of EAC 1, 4, 2 was inhibited. To explain the inhibition, the authors postu- 
lated either (a)  that large quantities of a  normal or an abnormal inhibitor of 
complement activation was present in the nephritic serum or (b) that comple- 
ment-inactivating  complexes were  either  present  in  the  nephritic  serum  or 
formed on mixing nephritic serum with guinea pig serum. The latter explanation 
was  favored in  view  of  the  belief that  the  forms of  nephritis  studied  were 
"complex" diseases. 
The relation of this inactivator of guinea pig complement to C3LyNeF must 
remain conjectural. In preliminary studies in our laboratory it would appear 
that C3NeF is not present or present only in low concentration in the serum 
of patients with acute poststreptococcal nephritis.  Since Pickering found high 
concentrations  of  inactivator in  such  serum  it  would  appear  that  the  phe- VALLOTA, FORRISTAL, SPITZER, DAVIS, AND  WEST  1321 
nomenon he was observing was either dependent on a different mechanism or 
his method of measuring inactivator had a different sensitivity. 
It should be noted that the results of the present study can be interpreted in a 
different way. One could speculate that an enzyme is normally present in serum 
which will cause rapid breakdown of C3 but is prevented from acting by being 
complexed to an inhibitor. In nephritis, an antagonist to the inhibitor could be 
generated which has the ability to activate the enzyme by reacting with the 
inhibitor. In this scheme C3NeF would be the antagonist, cofactor, the enzyme- 
inhibitor complex, and C3LyNeF, the activated enzyme. To comply with the 
data of the present paper, the enzyme and inhibitor could not exist separately 
in normal serum but would have to be present as a complex. 
Rather than an enzyme-inhibitor complex and its antagonist, it seems more 
logical to explain the present data by combination of C3NeF with cofactor to 
form C3LyNeF because of the analogies of this system with that for the cobra 
venom factor. It was shown by Mtiller-Eberhard et al. (29) that when a fraction 
of cobra venom known as cobra venom factor (CoF) is added to normal serum 
in the presence of divalent cation, a substance with a sedimentation rate of 9S is 
formed which has the property of rapidly cleaving C3.  CoF alone is inactive. 
Since CoF has  a  sedimentation rate of 7S  and the precursor is 5S,  it would 
appear that a complex formed of CoF and precursor is responsible for C3 lysis. 
Complex formation was confirmed by the observation that radio-labeled CoF 
was incorporated into the C3 inactivator. The several points of similarity be- 
tween the cobra venom complex and the lytic nephritic factor makes it attrac- 
tive to assume that they are analogous in the reaction sequence leading to their 
formation. 
Recent studies (30)  have indicated that the cobra venom complex not only 
inactivates but also activates guinea pig C3, producing lysis of sheep and guinea 
pig erythrocytes in the absence of antibody and in the absence of C1, C4, and 
C2.  The many points of similarity of the two systems makes it possible that 
C3LyNeF could likewise activate the terminal components of complement and 
produce  inflammatory  reactions  and  lysis.  Preliminary  experiments  in  this 
laboratory have supported this assumption. 
Assuming  that  the  complement  sequence  can  be  activated  by  C3LyNeF 
starting with C3, the question arises as to whether C3LyNeF is responsible for 
the renal damage in nephritis. If C3LyNeF produced temporary activation of 
C3 and of the last five components at an appropriate receptor site in the renal 
glomerulus, it might be an important factor in the initiation and maintenance 
of glomerular inflammation.  On  the  other hand,  it  is  possible  that  C3NeF, 
like  CoF  (31),  can  prevent  the  inflammatory process  initiated  by  antigen- 
antibody reactions  in  vivo by inactivating  C3.  Thus,  by keeping  C3  levels 
persistently low, C3NeF could act as a protective mechanism. As yet informa- 
tion is not available to allow a choice between these possibilities. 1322  NON-COMPLEMENT-DEPENDENT C3-REACTIVE COMPLEX 
Whatever the role of C3NeF, it represents the first observation in man of a 
circulating,  disease-associated,  non-complement  mechanism  which  causes 
inactivation of a  specific complement component.  It appears to represent  the 
postulated analogue of the cobra factor in the mammal (29). 
SUMMARY 
When serum from a patient with membrano-proliferative glomerulonephritis 
and normal serum are mixed at 37°C,  C3 is rapidly broken down to two more 
rapidly  migrating  components.  In  the  mixture,  a  heat-labile pseudog]obulin, 
designated as the C3 nephritic factor or C3NeF,  reacts with a pseudogolbulin 
in  the  normal  serum,  designated  as  cofactor,  to form a  C3  inactivator.  By 
analogy with the cobra venom factor, the C3 inactivator is most likely a com- 
plex of the nephritic factor and cofactor. The complex has been designated as 
the  C3  lyric nephritic factor or C3LyNeF.  The reaction which  results  in  the 
formation of C3LyNeF requires  the presence of Mg  ++,  is highly temperature 
sensitive but occurs very rapidly at 37°C.  In 20  rain at 37°C,  C3LyNeF can 
break down over 80% of the C3 in a mixture of normal and nephritic serum. 
The  two-step reaction  which  leads  to  C3  breakdown has  an  optimum  pH 
ranging from 6.0 to 9.0.  Experiments employing serum depleted of C4 and C2, 
as well as certain characteristics of the  C3NeF  system provide evidence that 
C3 breakdown with nephritic serum is not dependent on complement-inactivat- 
ing immune complexes or  on  the  action  of  convertase (C4, 2).  Data relating 
rate of C3 breakdown to the concentrations of C3NeF,  C3,  and C3LyNeF in 
the reaction mixture are similar to those for the reaction of enzyme with sub- 
strate. The biological significance of C3LyNeF in the production of glomerular 
inflammation has not been established. 
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